Revenue segments as reported by the company.

U.S. Healthcare Solutions

International Healthcare Solutions

Pharmaceutical Distribution Services

Other

Intersegment eliminations

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Distribution, selling, and administrative

Depreciation and amortization

Employee severance, litigation, and other

Goodwill impairment

Impairment of assets

Acquisition, integration, and restructuring expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

AmerisourceBergen

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Cardinal Health

McKesson

Teva Pharmaceutical

CLEVELAND – Four drug companies reached a last-minute legal settlement over their role in the opioid addiction epidemic just as a nine-week trial was scheduled to start in Cleveland, the Wall Street Journal reported Monday.

Four drug companies reach legal settlement for role in opioid addiction epidemic

But drug companies still have thousands of other opioid cases to contend with.

$260 Million Settlement Averts First Federal Opioid Trial

Four drug companies reached a last-minute legal settlement over their role in the opioid addiction epidemic just as a nine-week trial was scheduled to start in Cleveland, the Wall Street Journal reported Monday.

Drug companies reach settlement as opioid trial set to begin

Four drug companies on Monday reached a settlement deal with two Ohio counties on the fight over who is responsible for the opioid epidemic that has ravaged the United States, according to a report in The Wall Street Journal.

Four drug companies reportedly reach a last-minute opioid settlement with two Ohio counties

Johnson & Johnson

The biggest drug distributors, plus Johnson & Johnson and Teva Pharmaceutical, are reportedly on the brink of a $50 billion deal to settle thousands of cases related to the opioid epidemic.

Drug Suppliers Reportedly Near $50 Billion Deal In Opioid Lawsuits

Talks to settle opioid lawsuits sent drug distributor stocks soaring. Trade names at the center of the discussions using these strategies.

Drug Distributor Stocks Rally Amid Opioid Talks

Shares of companies embroiled in the U.S. opioid crisis were trading sharply higher Wednesday following a Tuesday Wall Street Journal report that said three opioid drug distributors are in talks with state and local governments regarding a settlement agreement.

Opioid Drug Companies Rally On Hopes of Broader Settlement

Shares of McKesson Corp. MCK, +6.21% rallied 5.7% in midday trading Wednesday, enough to pace all of its larger-capitalization health care peers, after The Wall Street Journal reported that the drug distributor, and two others, were in talks to pay $18 billion to settle all litigation brought by state and local governments blaming the companies for fueling the opioid crisis.

McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks

AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for AmerisourceBergen (ABC)

AECOM

Anixter

Best Buy

CVS Health

Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.

5 Stocks in the Limelight After Recent Broker Rating Upgrade

AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?

AmerisourceBergen (ABC) Down 10.3% Since Last Earnings Report: Can It Rebound?

Asbury Automotive Group

Cincinnati Bell

Since brokers follow stocks in their coverage minutely, their advice is invaluable for individual investors as the latter aim for lucrative returns.

Recent Broker Rating Upgrades Add Luster to These 5 Stocks

Let's see if AmerisourceBergen (ABC) stock is a good choice for value-oriented investors right now from multiple angles.

Is AmerisourceBergen (ABC) a Great Stock for Value Investors?

AutoNation

Clearwater Paper

Diebold Nixdorf Inc

Investors aim to generate maximum returns from their portfolio. Therefore, it is in their best interests to pay heed to well-researched information accumulated by brokers.

5 Stocks That Brokers Currently Love

AmerisourceBergen (ABC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Why AmerisourceBergen (ABC) is Such a Great Value Stock Pick Right Now

Chairman, President & CEO of Amerisourcebergen Corp (30-Year Financial, Insider Trades) Steven H Collis (insider trades) sold 19,905 shares of ABC on 08/05/2019 at an average price of $89.58 a share.

Amerisourcebergen Corp (ABC) Chairman, President & CEO Steven H Collis Sold $1..

AmerisourceBergen Corp (ABC) CEO Steve Collis on Q3 2019 Results - Earnings Call Transcript

The drug wholesaler kept its 2019 momentum going with solid revenue and earnings growth.

Here's What You'll Want to Know About AmerisourceBergen's Third-Quarter Earnings Beat

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.98% and 0.01%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) Tops Q3 Earnings and Revenue Estimates

Twenty-First Century Fox

Disney

Comcast

ABC, CBS, Fox, NBC sue small streaming-TV startup Locast

Builders FirstSource

Party City Holdco

The opinion of brokers is highly valued by investors as they have a clear insight into the nitty gritty of the investment world.

Recent Analyst Upgrades Add Shine to These 5 Stocks

Better-than-expected performance at Pharmaceutical Distribution and higher revenues are likely to aid AmerisourceBergen (ABC) in Q3 earnings.

AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing?

AmerisourceBergen is a well-managed and well-run company.

AmerisourceBergen: Buy The Stock And Forget It

Anglogold Ashanti Plc

CACI

Ford Motor Company

Oracle

While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.

5 Discounted PEG Stocks Suitable for Value Investors

Anthem

Centene

Humana

The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.

News for AmerisourceBergen Stock (ABC)